J&J COVID Vaccine Added $502 Million to Third-Quarter Sales
The company’s earnings beat Wall Street’s profit expectations but revenue missed forecasts.
Johnson & Johnson Q1 Profit, Sales Jump, Beat Street Views
Big jumps in sales of prescription drugs & medical devices helped Johnson & Johnson boost its first-quarter profit by nearly 7%.
With the Competition Struggling, Pfizer’s Covid Vaccine Sales Could Hit $24b This Year
mRNA COVID-19 vaccines are sailing along as viral vector shots encounter setback after setback. How will it affect vaccine sales in 2021?
Johnson & Johnson Asks FDA To Authorize Its COVID-19 Vaccine
The US government has ordered 100 million doses and J&J says it can meet this commitment by June.